Literature DB >> 26508322

Neural response during anticipation of monetary loss is elevated in adult attention deficit hyperactivity disorder.

Gregor Wilbertz1,2,3, Mauricio R Delgado4, Ludger Tebartz Van Elst2, Simon Maier2, Alexandra Philipsen2,5, Jens Blechert6,7.   

Abstract

OBJECTIVES: Risky behaviour seriously impacts the life of adult patients with attention deficit hyperactivity disorder (ADHD). Such behaviours have often been attributed to their exaggerated reward seeking, but dysfunctional anticipation of negative outcomes might also play a role.
METHODS: The present study compared adult patients with ADHD (n = 28) with matched healthy controls (n = 28) during anticipation of monetary losses versus gains while undergoing functional magnetic resonance imaging (fMRI) and skin conductance recording.
RESULTS: Skin conductance was higher during anticipation of losses compared to gains in both groups. Affective ratings of predictive cues did not differ between groups. ADHD patients showed increased activity in bilateral amygdalae, left anterior insula (region of interest analysis) and left temporal pole (whole brain analysis) compared to healthy controls during loss versus gain anticipation. In the ADHD group higher insula and temporal pole activations went along with more negative affective ratings.
CONCLUSIONS: Neural correlates of loss anticipation are not blunted but rather increased in ADHD, possibly due to a life history of repeated failures and the respective environmental sanctions. Behavioural adaptations to such losses, however, might differentiate them from controls: future research should study whether negative affect might drive more risk seeking than risk avoidance.

Entities:  

Keywords:  ADHD; anticipation; fMRI; monetary loss; reward

Mesh:

Year:  2015        PMID: 26508322     DOI: 10.3109/15622975.2015.1112032

Source DB:  PubMed          Journal:  World J Biol Psychiatry        ISSN: 1562-2975            Impact factor:   4.132


  7 in total

1.  Salience network coupling is linked to both tobacco smoking and symptoms of attention deficit hyperactivity disorder (ADHD).

Authors:  A C Janes; J M Gilman; B B Frederick; M Radoman; G Pachas; M Fava; A E Evins
Journal:  Drug Alcohol Depend       Date:  2017-11-21       Impact factor: 4.492

2.  The relationship between responsiveness to social and monetary rewards and ADHD symptoms.

Authors:  Bernis Sutcubasi; Baris Metin; Cumhur Tas; Fatma Keskin Krzan; Berna A Sarı; Betul Ozcimen; Nevzat Tarhan
Journal:  Cogn Affect Behav Neurosci       Date:  2018-10       Impact factor: 3.282

3.  Reward Processing in Drug-Naive Youth with Various Levels of Risk for Substance Use Disorders: A Pilot Study.

Authors:  Iliyan Ivanov; Kurt Schulz; Xiaobo Li; Jeffrey Newcorn
Journal:  J Child Adolesc Psychopharmacol       Date:  2019-06-10       Impact factor: 2.576

4.  Anterior insula hyperactivation in ADHD when faced with distracting negative stimuli.

Authors:  Nora C Vetter; Judith Buse; Lea L Backhausen; Katya Rubia; Michael N Smolka; Veit Roessner
Journal:  Hum Brain Mapp       Date:  2018-03-23       Impact factor: 5.038

Review 5.  Cognitive Neuroscience of Attention Deficit Hyperactivity Disorder (ADHD) and Its Clinical Translation.

Authors:  Katya Rubia
Journal:  Front Hum Neurosci       Date:  2018-03-29       Impact factor: 3.169

6.  The limits of motivational influence in ADHD: no evidence for an altered reaction to negative reinforcement.

Authors:  Jeroen Van Dessel; Edmund J S Sonuga-Barke; Matthijs Moerkerke; Saskia Van der Oord; Sarah Morsink; Jurgen Lemiere; Marina Danckaerts
Journal:  Soc Cogn Affect Neurosci       Date:  2022-05-05       Impact factor: 4.235

7.  Abnormal Functional Connectivity in Cognitive Control Network, Default Mode Network, and Visual Attention Network in Internet Addiction: A Resting-State fMRI Study.

Authors:  Yang Wang; Yun Qin; Hui Li; Dezhong Yao; Bo Sun; Zhiliang Li; Xin Li; Yu Dai; Chao Wen; Lingrui Zhang; Chenchen Zhang; Tianmin Zhu; Cheng Luo
Journal:  Front Neurol       Date:  2019-09-18       Impact factor: 4.003

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.